Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
-1.72%
)
Bitcoin
70,345.55
(
-0.24%
)
News Focus
News Focus

Replies to post #171463 on Biotech Values

Replies to #171463 on Biotech Values
icon url

oc631

12/18/13 10:36 AM

#171464 RE: caravon #171463

I'm in the process of buying ENTA as we speak.
icon url

oc631

12/18/13 10:40 AM

#171465 RE: caravon #171463

I will not sell Abbott short regarding to marketing. Abbott has an outstanding marketing expertise and capabilities. With all these numbers coming from HCV trials, the marketing will be the key.




I agree 100%.
icon url

DewDiligence

12/18/13 4:24 PM

#171492 RE: caravon #171463

AbbVie (ABBV), not Abbott (ABT). They have been separate companies since 1/1/13.